Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRent ExpenseRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

National Healthcare Properties (NHPBP) Other Non Operating Income (2016 - 2025)

National Healthcare Properties has reported Other Non Operating Income over the past 12 years, most recently at -$329000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 51.97% year-over-year to -$329000.0; the TTM value through Dec 2025 reached $196000.0, down 27.14%, while the annual FY2025 figure was -$72000.0, 118.37% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$329000.0 at National Healthcare Properties, down from $294000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $3.8 million in Q4 2022 and troughed at -$685000.0 in Q4 2024.
  • A 5-year average of $346333.3 and a median of $115000.0 in 2023 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 16665.22% in 2022 and later tumbled 533.54% in 2024.
  • Year by year, Other Non Operating Income stood at -$23000.0 in 2021, then skyrocketed by 16665.22% to $3.8 million in 2022, then crashed by 95.85% to $158000.0 in 2023, then tumbled by 533.54% to -$685000.0 in 2024, then surged by 51.97% to -$329000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for NHPBP at -$329000.0 in Q4 2025, $294000.0 in Q3 2025, and $231000.0 in Q2 2025.